ACAD
26.76
-0.48
-1.76%
AEMD
4.81
+0.01
+0.21%
APRI
1.14
-0.06
-5.00%
ARNA
1.41
+0.04
+2.92%
ATEC
4.9
+0.02
+0.41%
CNAT
1.94
+0.03
+1.57%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.6
+0.04
+2.56%
DXCM
65.01
+0.4
+0.62%
GNMK
10.96
-0.22
-1.97%
HALO
11.53
-0.1
-0.86%
ILMN
123.2
-0.28
-0.23%
INNV
0.259
-0.001
-0.44230%
INO
7.14
+0.01
+0.14%
ISCO
1.68
+0.17
+11.26%
ISIS
0
0.00
0.00%
LGND
104.48
+0.85
+0.82%
LPTN
2.615
+0.115
+4.600%
MBVX
3.97
+0.12
+3.12%
MEIP
1.58
+0.02
+1.28%
MNOV
7.17
-0.28
-3.76%
MRTX
5.9
+0.3
+5.36%
MSTX
0.122
+0.003
+2.6050%
NBIX
41.66
-0.05
-0.12%
NUVA
67.84
-0.15
-0.22%
ONCS
1.44
+0.13
+9.92%
ONVO
3.31
+0.01
+0.30%
OREX
2
+0.06
+3.09%
OTIC
18.15
+0.75
+4.31%
QDEL
23.04
+0.31
+1.36%
RCPT
0
0.00
0.00%
RGLS
2.5
-0.1
-3.85%
RMD
62.23
+0.86
+1.40%
SCIE
0.002
0.00
-9.6386%
SPHS
2.72
-0.03
-1.09%
SRNE
5.4
-0.05
-0.92%
TROV
2.5
-0.15
-5.66%
VICL
2.5
+0.04
+1.63%
ZGNX
12.15
-0.2
-1.62%
ACAD
26.76
-0.48
-1.76%
AEMD
4.81
+0.01
+0.21%
APRI
1.14
-0.06
-5.00%
ARNA
1.41
+0.04
+2.92%
ATEC
4.9
+0.02
+0.41%
CNAT
1.94
+0.03
+1.57%
CRXM
0.17
+0.00
+0.0589%
CYTX
1.6
+0.04
+2.56%
DXCM
65.01
+0.4
+0.62%
GNMK
10.96
-0.22
-1.97%
HALO
11.53
-0.1
-0.86%
ILMN
123.2
-0.28
-0.23%
INNV
0.259
-0.001
-0.44230%
INO
7.14
+0.01
+0.14%
ISCO
1.68
+0.17
+11.26%
ISIS
0
0.00
0.00%
LGND
104.48
+0.85
+0.82%
LPTN
2.615
+0.115
+4.600%
MBVX
3.97
+0.12
+3.12%
MEIP
1.58
+0.02
+1.28%
MNOV
7.17
-0.28
-3.76%
MRTX
5.9
+0.3
+5.36%
MSTX
0.122
+0.003
+2.6050%
NBIX
41.66
-0.05
-0.12%
NUVA
67.84
-0.15
-0.22%
ONCS
1.44
+0.13
+9.92%
ONVO
3.31
+0.01
+0.30%
OREX
2
+0.06
+3.09%
OTIC
18.15
+0.75
+4.31%
QDEL
23.04
+0.31
+1.36%
RCPT
0
0.00
0.00%
RGLS
2.5
-0.1
-3.85%
RMD
62.23
+0.86
+1.40%
SCIE
0.002
0.00
-9.6386%
SPHS
2.72
-0.03
-1.09%
SRNE
5.4
-0.05
-0.92%
TROV
2.5
-0.15
-5.66%
VICL
2.5
+0.04
+1.63%
ZGNX
12.15
-0.2
-1.62%
Home » Archive by Category

Syndication

NovogeneAIT Singapore and the Genome Institute of Singapore Forge Public-Private Partnership to Establish Whole Genome Sequencing Centre in Singapore

December 8, 2016 – 6:00 am

SINGAPORE, BEIJING, and SAN DIEGO, Dec. 8, 2016 /PRNewswire/ — Novogene, a leading commercial provider of genomic services and solutions with cutting edge next-generation sequencing and bioinformatics expertise; AITbiotech Pte Ltd, a Singapore biotechnology company; and the Genome Institute of Singapore (GIS) announced today that NovogeneAIT Genomics Singapore (NovogeneAIT) – a new joint venture between Novogene and AITbiotech – will establish a joint whole genome sequencing (WGS) centre at Biopolis, Singapore.  

The new centre will provide Illumina HiSeq X based whole genome sequencing and bioinformatics analysis of human, plant and animal samples for biomedical and agricultural researchers. The centre will devote a major portion of its sequencing capability to support public research projects and empower super scale sequencing initiatives in Singapore and the region. In addition, NovogeneAIT will collaborate with GIS to develop new applications of next-generation sequencing, such as WGS solutions for cancer diagnosis and stratified cancer treatment.

“I am very excited and pleased to announce this significant new initiative with the Genome Institute of Singapore,” stated Dr. Ruiqiang Li, CEO of Novogene. “The centre is the first major project for NovogeneAIT and is an important milestone for our company. We look forward to providing high-quality sequencing services in Singapore and to advancing important research initiatives that can benefit humanity.”

“We are delighted to work with a local biotech company,” said Prof. Ng Huck Hui, Executive Director of GIS. “Such public-private partnerships will prove to be highly beneficial as it leverages the strengths of both parties to advance genomic science and medicine in Singapore, as well as to create successful local biotech companies.”

About Novogene Corporation
Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and one of the largest sequencing capacities in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help our clients realize their research goals in the rapidly evolving world of genomics. With 1,300 employees, multiple locations around the world, 43 NGS related patents, and over 200 publications in top tier journal such as Nature and Science, the company has rapidly become a world-leader in NGS services. For more information, visit http://en.novogene.com.

NovogeneAIT, a newly formed joint venture between Novogene and AITbiotech announced in September 2016, provides Illumina HiSeq X based NGS services to the Association of Southeast Asia Nations (ASEAN) and other Asian regions.

About AITbiotech
AITbiotech is a leading Genomic Services and MDx company based in Singapore. Founded by Alex Thian in 2008, it has a core molecular services and R&D laboratory in Singapore managed by a team of experienced biotechnologists. It provides a complete suite of Genomic Services including Capillary Sequencing, Next-generation Sequencing Services, Bioinformatics Services and customized molecular services to the research, healthcare and biomedical industries in Singapore and Asia. AITbiotech is also an ISO 13485 certified company which manufactures and distributes its own line of real-time PCR pathogen detection assays branded as abTESTM in the Asian and European markets. For more information, please visit our website: www.aitbiotech.com.

About A*STAR’s Genome Institute of Singapore (GIS)
The Genome Institute of Singapore (GIS) is an institute of the Agency for Science, Technology and Research (A*STAR). It has a global vision that seeks to use genomic sciences to achieve extraordinary improvements in human health and public prosperity. Established in 2000 as a centre for genomic discovery, the GIS will pursue the integration of technology, genetics and biology towards academic, economic and societal impact.

The key research areas at the GIS include Human Genetics, Infectious Diseases, Cancer Therapeutics and Stratified Oncology, Stem Cell and Regenerative Biology, Cancer Stem Cell Biology, Computational and Systems Biology, and Translational Research.

The genomics infrastructure at the GIS is utilised to train new scientific talent, to function as a bridge for academic and industrial research, and to explore scientific questions of high impact.

For more information about GIS, please visit www.gis.a-star.edu.sg

Media contacts:

Mr Alex Thian
AITbiotech                      
+65 6778 6822                            
alex@aitbiotech.com
www.aitbiotech.com

Joyce Peng, Ph.D.
Global Marketing Director and General Manager
Novogene Corporation
+1-626-222-5584
joyce.peng@novogene.com

Joyce Ang
Senior Officer, Office of Corporate Communications
Genome Institute of Singapore, A*STAR
+65 6808 8101
angjj@gis.a-star.edu.sg

 

SOURCE Novogene Corporation

Clinical Study Manager – San Diego – Mendeley – San Diego, CA

December 8, 2016 – 5:50 am

We’re proud to partner with the industry’s leading Pharmaceutical, Biotechnology, Medical Device, Marketing Communications and Contract Research Organisations…
From Mendeley – Thu, 08 Dec 2016 12:50:15 GMT – View all San Diego jobs

Craig Venter Used Own Posh Health Clinic To Diagnose His Cancer

December 8, 2016 – 5:17 am

Speaking at a conference in San Francisco Wednesday, geneticist Craig Venter revealed that he had just had surgery for prostate cancer three weeks ago. A health workup at his own high-end clinic,…

[[Click headline to continue reading.]]

R&D Scientist (Sorrento Valley)

December 8, 2016 – 12:25 am

Research & Development Scientist
Summary:
A startup company at Sorrento Valley, dedicated to developing novel direct consumer diagnostics, has an immediate opening for R&D scientist working on lateral flow assay development.
Responsibilities:
? R […]

Wake Up, Pharma—Trump Is Not Your Savior

December 7, 2016 – 10:01 pm

Since the election, leaders in biotechnology and pharmaceuticals are acting like they got away with robbery. The Nasdaq Biotechnology Index went up 9 percent overnight on November 8th. With Donald…

[[Click headline to continue reading.]]

Senior Network Engineer / DevOps Engineer (VMware, Azure, Powershell) – Jobspring Partners – San Diego, CA

December 7, 2016 – 8:25 pm

Great biotechnology company building out revolutionary technology. San Diego’s most advancing cancer diagnostics company is looking for a talented Sr…. $90,000 – $120,000 a year
From Jobspring Partners – Thu, 08 Dec 2016 03:25:00 GMT – View all San Diego jobs

Glass Wash Technician (La Jolla)

December 7, 2016 – 6:19 pm

We currently have full time openings for Glass Ware Technicians.
Responsibilities include:
? Collect glassware, wash, and autoclave. Then return to designated areas.
? Ethanol Dilution: Mixing ethanol and DI water to dilute to 70% proof.
? Bleach […

Biocom Applauds Passage of 21st Century Cures Legislation

December 7, 2016 – 5:15 pm

SAN DIEGO, Dec. 7, 2016 /PRNewswire/ — Biocom, the association for the California life science community, issued the statement below following passage of 21st Century Cures legislation in Congress. The bill passed in the House on November 30 by a 392-26 vote and in the Senate on December 7 by a 94-5 vote. This statement may be attributed to Joe Panetta, president & CEO of Biocom:

“Today, Congress approved historic legislation that will give hope to millions of patients around the world. The measure culminates three years of hard work and dedication from government, industry, the patient community, and many others, all committed to one goal: finding treatments and cures to the world’s most dreaded diseases. Today, we are one step closer to achieving that goal.

“This landmark legislation addresses some of the most pressing challenges that currently hinder biomedical innovation and the development of the next generation of innovative products. The bill increases funding for research at the National Institutes of Health (NIH), including for the Precision Medicine Initiative, Cancer Moonshot Initiative, BRAIN Initiative, and regenerative medicine. It also makes much needed changes to our regulatory environment to ensure that patients have access to life-enhancing and life-saving medicines faster.

“While Biocom had supported additional funding for the NIH, we applaud this large-scale, bipartisan, and collaborative effort that will change the future of innovation in the United States. We look forward to working with the new Administration and Congress over the coming years on the implementation of the bill and on issues that were not addressed in the bill, including the reimbursement of telemedicine, remote patient monitoring services, and other emerging technologies, that together represent the future of modern medicine.”

About Biocom
Biocom is the largest, most experienced leader and advocate for California’s life science sector. We work on behalf of more than 800 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs. Founded in 1995 in San Diego, Biocom provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to its San Diego headquarters, Biocom operates a core office serving the Los Angeles market, satellite offices in Washington, D.C. and Tokyo, and has a continuous staff presence in Sacramento and San Francisco. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers. For more information, visit us at www.biocom.org. Connect with us on LinkedIn, Facebook, and Twitter (@BIOCOMCA).

Logo – http://photos.prnewswire.com/prnh/20130228/LA69104LOGO

 

SOURCE Biocom

Scientist I – Pacira Pharmaceuticals – San Diego, CA

December 7, 2016 – 4:46 pm

Extensive knowledge of analytical techniques utilized in Pharmaceutical and Biotech industries. Design, execute and interpret experimental results….From Pacira Pharmaceuticals – Wed, 07 Dec 2016 23:46:48 GMT – View all San Diego jobs

Attorney – Illumina, Inc. – San Diego, CA

December 7, 2016 – 4:32 pm

Regulated products or biotechnology is preferred but not required. The selected candidate will draft and review various contracts to support the internal…From Illumina, Inc. – Wed, 07 Dec 2016 23:32:51 GMT – View all San Diego jobs